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Executive Summary
Emergency contraception (EC) affords the opportunity of avoiding an unintended pregnancy after unprotected sexual intercourse. In its most common form, oral contraceptive pills, EC provides protection for up to 120 hours after intercourse. Alternatively, an intra-uterine contraceptive device (IUCD) can be inserted, no later than five or six days after intercourse. IUCDs have proven effective and, by expanding contraceptive choices, have transformed the sexual and reproductive lives of millions of women around the world. Despite significant progress in product development, procurement, and distribution in the past few decades, EC's capacity to benefit many women, in countries such as Nigeria, is hampered by several issues, including EC knowledge, attitudes, and practices among providers and opinion leaders, all of which are perceived as potential barriers to EC, but are not well understood.
To better understand these issues, The Population Council, with support from the International Consortium for Emergency Contraception, documented EC-related knowledge, attitudes, and practices among EC providers in Nigeria. Recognizing that providers do not operate in a vacuum, this study also assessed perceptions of key opinion leaders (KOLs) who help shape the policy environment for EC and family planning (FP) in general. The study is a part of a multi-country project also including India and Senegal.
Findings suggest significant gaps in provider EC knowledge, attitudes, and practices in Nigeria, potentially necessitating continuous training and re-training to help dispel misperceptions and negative attitudes. For example, many providers will not distribute EC to young, unmarried women, and clear instructions or counseling are rarely included when EC is provided. Moreover, almost all sampled providers were not aware that dedicated EC pills can provide protection for as many as five days postintercourse, despite its categorical statement in the country's FP service protocols.
Introduction
Studies have shown a high proportion of all pregnancies in sub-Saharan Africa are unintended (Cleland et al. 2011) . As a result, many end in termination through induced abortion. In countries such as Nigeria, where abortion law is highly restrictive, termination is commonly performed by unqualified persons, or in places not meeting required sanitary and technical standards, thereby propagating unsafe abortion, an important contributor to unacceptably high maternal mortality and morbidity ratios in many developing countries (Population Council and PSI 2009) . Unsafe abortion remains a serious challenge to Nigeria's health system, a country with a maternal mortality ratio (MMR) estimated at 545 maternal deaths per 100,000 live births (NPC 2009 ). Unsafe abortion, as a result of unintended pregnancies, is identified as one of the leading causes of maternal deaths in Nigeria (Ebuehi et al. 2006 ).
With stringent legal and social restrictions to safe abortion in Nigeria, EC could play an important role in preventing unintended pregnancies, among both married and unmarried women who have had unprotected intercourse. EC is safe and effective in preventing unintended pregnancy, by either inhibiting or delaying, before ovulation, ovarian egg release, or potentially preventing sperm and egg convergence, by affecting cervical mucus or spermal binding ability. Although Nigeria's Federal Ministry of Health National Family Planning Guidelines lists EC among other modern contraceptive methods as a nonprescription drug sold over the counter, EC use remains very low in Nigeria (FMoH 2010 , NPC 2009 ).
Few studies in recent years, however, have investigated provider EC knowledge, attitudes, and practices in Nigeria, and to the best of our knowledge, no study has investigated KOLs' EC perceptions and attitudes. The knowledge, attitudes and practices of EC providers, who are key gatekeepers, must be investigated, with gaps therein addressed. Perceptions of policy makers who both shape the general FP commodity environment, including EC, and enforce regulations affecting provider practices, need to be assessed. These issues constitute the study's main focus.
Review of the literature

Providers' EC knowledge
A 1998 study by the Society for Family Health (SFH) demonstrated a paucity of EC knowledge among health care providers in Nigeria. Only 61 percent of interviewed providers across the country knew of an EC method; Postinor was the only pill specifically packaged for EC (Society of Family Health 1998). EC knowledge varied regionally: It was higher in the southern zone than in the north (SFH 1998). In the southwest region, where EC knowledge seems high, only 33 percent of providers knew any effective method, with wide rural-urban differences (22.4% and 5.8% respectively). Local pharmacy personnel were most aware of effective contraception methods, while those at patent medical stores showed poorest understanding of effective EC methods (SFH 1998).
The SFH study also reported that 29 percent of providers expressed belief that EC could result in infertility. Prescription method inconsistency also prevailed, reflecting a lack of detailed knowledge. No providers interviewed knew Postinor's dosage, side effects, and mechanisms of action, and only five providers (of 443) correctly stated the timing, as an EC agent, of IUCD insertion (SFH 1998).
The knowledge and attitudes of other trained health professionals, such as doctors, nurses, pharmacists, and hospital administrators, have been studied by Adekunle et al. (2000) in Ibadan, and their findings were not significantly different. For example, only 35 percent of respondents were aware that combined estrogen/progestin or progestin-only pills can be used as EC, and only 27 percent were aware IUCDs could be used as EC. Similarly, Obionu (1998) found, in Enugu, southeast Nigeria, that only 39 percent of health professionals were aware of an EC pill, and fewer still (26%) were aware of IUCDs' potential contraceptive use. More worryingly, 29 percent of the sample who knew of an EC product expressed the belief its use was associated with infertility.
Although recent studies suggest improvement in EC provider knowledge in Nigeria, the situation is still far from ideal. As recently as 2006, 90 percent of health providers in Lagos State knew of an EC method, and 75 percent knew it could prevent pregnancy, but only 50 percent knew correct timing of administration, and only 10 percent were able to recognize the drug, its side effects, and dosage (Deborah 2007 , Ebuehi et al. 2006 . Most alarmingly, only two thirds of providers who knew of an EC method were aware it is legal in Nigeria. Okonofua et al. (2009) reported, from a survey of private medical practitioners (mainly doctors) in four Nigerian geo-political zones, that, while 80 percent of respondents correctly described EC methods, only 14 percent reported correct brands and dosages of ECs currently available in the country, and fewer still knew the exact timing for EC use. Fayemi et al. (2010) report that the preferred service delivery point for EC in Nigeria, especially among young women, is patent medicine vendors, but only 46 percent of these vendors could correctly describe an EC, in terms of pregnancy prevention use. Less than 10 percent of patent vendors said it is a drug used after sex, and only three percent could mention a brand name (Postinor).
In another study, about 80 percent of senior health professionals in Borno State (Northeast Nigeria) reported hearing of EC, with awareness lower among nurses (70%). Even so, up to 10 percent of these respondents were not sure of the correct timing of administration (Geidam, Kullima and Saddiq 2009) . Table 1 summarizes selected findings from previous research on EC knowledge among providers. 
Providers' attitudes towards EC
Previous studies of EC providers also report findings on attitudes. Society for Family Health (1998), for example, found about 80 percent of all providers in Nigeria approved of EC, across all regional, religious, ethnic, and gender categories. Among the minority of providers disapproving of EC, reasons included religious belief, adverse side effects, EC as abortificient, and its use encouraging immorality, especially by unmarried adolescents (Deborah 2007 , Ebuehi et al. 2006 , Adekunle et al. 2000 . It is not surprising, therefore, the majority of doctors, nurses, and pharmacists interviewed in Ibadan identified sexual assault (64%) as the only appropriate indication for EC (Adekunle et al. 2000) . Table 2 describes documented common negative attitudes towards EC in Nigeria. The current study provides opportunity for better understanding EC provider attitudes in Nigeria in a range of issues, but particularly the question of repeated use, and describing changes that have potentially occurred in the intervening period.
Context and Rationale
Nigeria is the most populous country in Africa, with a 2010 estimated population of 160 million (Federal Government of Nigeria 2011). With a growth rate of 2.8 percent, the country is expected to double its population in 25 years if the current total fertility rate (5.7) and other determinants remain the same (Population Reference Bureau 2010). Nigeria's maternal and infant mortality are among the highest in the world: 545 per 100,000 and 75 per 1000, respectively (NPC 2009). Contraceptive prevalence for modern FP methods is 10 percent, and much lower for EC (less than 1%).
Within this demographic context, assessing FP providers' knowledge, attitudes, and practices, especially regarding EC, will improve understanding of and strengthening for the supporting environment for EC's supply and use. In addition, the perceptions of KOLs and policy makers, regulators of these environments, and important influencers of health-seeking behaviors, will be assessed. Once these issues become clearer, more definite programmatic recommendations could be made.
Two urban centers were purposively selected-Abuja and Kaduna, in central and northwest Nigeria, respectively. Abuja, the Federal Capital Territory, is home to all ethnic populations, with a total population of approximately 1.4 million. As the seat of federal government, Abuja attracts the young and energetic migrating there in search of employment and other opportunities. Regrettably, the majority of this population lives in sprawling slums, exposing them to poor and substandard housing, without clean water and basic sanitation, and with insecurity and poor health services.
Kaduna is traditionally the political center of northern Nigeria and, therefore, harbors a large number of migrants mostly residing in unplanned, poorly serviced settlements. The most recent census placed Kaduna's total population at nearly 800,000 (National Population Commission 2009a). Kaduna, as with the rest of the region, has health and development indices worse than national averages; for example, contraceptive prevalence for the Northwest region is 4.6 percent (NPC 2009b) .
Methodology
This study is a cross-sectional survey of providers' and stakeholders' beliefs, attitudes, and practices concerning EC provision and use in Kaduna and Abuja. A semi-structured questionnaire was developed, pilot-tested, and utilized for interviewing both public and private sector providers. Various stakeholders and KOLs directly or indirectly involved in providing, or influencing, continued EC availability and use were also interviewed using an in-depth interview (IDI) guide.
Provider survey
A simple, random sample of providers drew from a sampling frame (from health authorities in each city) consisting of a list of PMVs, private and public FP clinics, and registered pharmacists in Kaduna and Abuja. From every clinic or hospital (private or public) selected, the FP service head was interviewed, and from every selected pharmacy and patent medical store the proprietor was interviewed. From these sampling frames, 735 providers were selected. A pre-survey questionnaire indentified 550 providers in the two cities currently providing, or who have ever provided, EC. The minimum sample size was 364 and, allowing for non-response of 10 percent, a total of 407 providers were interviewed. To eliminate data entry errors and reduce time for data entry, a scan-able questionnaire for data collection was used, with data entered centrally. Data were cleaned, and files were created in EPI-INFO and SPSS. A codebook and frequency distribution of the variables and a plan of analysis and outline report with dummy tables were developed prior to data analysis and report writing.
Key Opinion Leaders' interviews
In Abuja, key stakeholders were purposively selected from members of the national legislative houses (i.e. chairs of the Senate and House of Representatives health committees); officials of the federal ministries of Health and Women's Affairs; heads of relevant professional associations such as the Nigeria Medical Association, Pharmacists' Council of Nigeria, and National Association of Nurses and Midwives; relevant pharmaceutical companies and leading social marketing organizations; religious leaders; and leaders of reproductive health (RH) and women's rights-focused civil society organizations (CSOs). Thirteen of these key stakeholders were interviewed by Council staff, and their responses were recorded with tape recorders and written notes, transcribed verbatim, with content analysis based on four pre-determined domains (see below).
Ethical considerations
IRB approval was obtained from both the Nigerian Institute for Medical Research (NIMR) and the Health Research Committee of the Federal Capital Development Authority (FCDA). Each participant was informed of the research's nature and was also informed that everything they said would remain confidential, their names would not be recorded, no payment would be made for participation, they had the right to not answer any question, and that they could terminate the interview at any point if they felt uncomfortable. Signed consent was obtained from every participant.
Study Findings
Providers' characteristics
The average age of the 407 providers was 35, with 56 percent male and 44 percent female, a reflection of the labor force's overall gender imbalance. Most providers interviewed were pharmacists (36%), followed by PMVs (30%), private sector hospital and clinic staff (22%), and public sector hospital and clinic staff (12%). The high proportion of pharmacists as EC providers indicates their gradual increase in EC dispensation, which may be a desirable development, since pharmacists are better qualified and more informed than PMVs about EC and modern contraception in general (SFH 1998).
Providers' EC knowledge, attitudes, and practices
In the 1990s, Postinor 2 was the only dedicated EC commodity available in Nigeria. This study revealed a broadening of the range of EC brands, indicated in Figure 1 . Three-quarters of providers could correctly describe how EC works, which displays remarkable progress since the 1990s, when no interviewed providers were aware of how Postinor 2 works (SFH 1998). Ten percent of providers still consider EC an abortifacient, but which is an improvement compared with earlier studies, which found up to 32 percent of providers in Lagos thought EC is an abortifacient (Deborah 2007 , Ebuehi et al. 2006 . Only 29 percent of providers knew, however, that all women are eligible for EC. Remarkably, only one provider (0.2%) was aware EC pills are protective for up to 120 hours after unprotected intercourse, despite current Nigerian EC service delivery guidelines clearly affirming this (Revised National Family Planning Service Protocols 2010).
Overall, only 12 percent of providers could be categorized as exhibiting comprehensive EC knowledge, knowing at least four of the five questions on EC knowledge. Factors significantly associated with comprehensive knowledge of how EC works included:
• Ever received FP counseling training, AOR 1.9 (CI1.02, 3.67)
• Ever received training on EC specifically, one year prior to survey AOR 1.54(CI 0.57, 4.18)
• Ever received a brochure/information document, AOR 1.67(CI 0.50, 5.23)
• Ever read an EC brochure/information document, AOR 1.91(CI 0.57, 6.69).
These patterns were also largely observed with other knowledge variables, as shown in Table 3 . Table 4 illustrates Nigerian providers' negative attitudes about EC. Although 94 percent of providers expressed the belief that EC is safe, some negative attitudes were observed as widespread among EC providers. Over 34 percent of providers did not believe EC is very effective in preventing pregnancy, and two-thirds did not favor EC's general availability, over the counter (OTC) without a prescription. By implication, the subject of repeated use was not accepted by providers, as only 23 percent and 18 percent agreed to no limit on EC use and EC provision whenever needed, respectively. Fifty-seven percent of providers, however, had repeatedly provided EC to a client.
Ever received EC training and being a provider at a public facility are positively associated with perceiving EC as safe; AORs 1.95 (95% CI 0.73, 5.23) and 1.57(95% CI 0.29, 8.42) respectively. Likewise, ever having read a brochure/information document on EC is significantly associated with believing EC is effective in preventing pregnancies; AOR 3.66 (95% CI 1.33, 10.08). Working at patent medical stores is strongly and positively indicative of positive attitudes toward providing EC to any woman who had unprotected intercourse. Table 5 (on page 13) indicates that belief in EC's efficacy for pregnancy prevention is strongly associated with prior exposure to specific information about EC. Table 6 describes the profile of EC users as reported by the providers. Most clients are predominantly students or unmarried (60%) and married women (54%); one quarter of providers indicated usually serving teenage adolescents (19 years or less). The quality of information and services offered to clients by the providers was poor. Only 20 percent and 14 percent of providers reported offering information on side effects and responding to queries and concerns respectively. In addition, 49 percent of the providers provide EC without giving instructions to their clients (Table 7) . Refer to family planning services 55 (13.5)
Key Opinion Leaders' insights
Stakeholders' support will, to a large extent, determine supply and demand, legality and regulation, awareness of and support for, and public facility distribution, or lack thereof, of EC (Williams 2011) . In some countries, EC availability and accessibility have stalled due to groups opposed to FP generally and those who perceive EC as abortifacient. EC's global availability and affordability, however, have increased over the last few years due multiple stakeholders' efforts (Schiappacasse and Diaz 2006) . In some African countries such as Kenya, changing of policy support has affected commodity availability and stability. As contraception policy expands and contracts, contraceptive availability and accessibility also fluctuate, with RH repercussions in general (Crichton 2008 ).
KOLs' role in matters of public health importance cannot, therefore, be overstated. In Nigeria, such stakeholders' perceptions of EC have not been carefully investigated. This study addresses the perceptions of these Nigerian policy stakeholders in four areas: EC product knowledge; EC policy issues; supply and demand; and their recommendations for improving EC supply and utilization.
KOLs' awareness of EC products in Nigeria
In general, stakeholder knowledge of EC is encouraging. Government stakeholders, however, are apparently not directly involved in EC regulation and have not played a role in EC in the past: Even among those seemingly conversant with EC and its legality in the country, their responses were more conjectural than factual, indicating remoteness from FP policy generally, and of EC particularly. When asked about EC status and product knowledge in Nigeria, the following responses emerged:
"That is what I said. I don't have any information about [EC'S legal status]." -Departmental deputy director, FMoH
"As I am telling you … Because we are not managing it [EC] in the public sector supply, I don't have detailed information [of available EC products], but I know the social marketing-SFH does that. So I don't know the brand, whether it is Postinor 2 or 1." -Departmental deputy director, FMoH
In contrast to public sector stakeholders, those working with NGOs and donor agencies seemingly understand the issue far better, which may reflect these different entities' roles in FP provision in general: 
"Well … legal status? Am not sure what you meant by that, but from my own understanding, do you mean if the drug is approved to be used in Nigeria? If that is what you mean … the answer is Yes! And in fact, the two products being distributed by Society for Family Health actually are registered by NAFDAC, which is the highest drug approval body in Nigeria, that is … Postinor 2 and Pregnor
Policy considerations for EC in Nigeria
Most participants supported the view that EC should, as a provision of the National Family Planning Policy, be made widely available as part of the contraceptive mix. There was overwhelming enthusiasm among stakeholders for supporting EC's availability to the younger population at risk of unprotected intercourse and its potential consequences. While most interviewees were uncertain of whether national EC guidelines in Nigeria exist, EC's availability and widespread distribution were strongly recommended by all interviewed stakeholders, and undoubtedly positive signal for EC policy in Nigeria. (contraceptive) 
"Yeah I think it is better (EC) as a part of the
Programmatic Implications
These research findings have several programmatic implications, both for providers and stakeholders. As less than half of EC providers in Nigeria have ever received training on EC, and as EC knowledge is directly related to such training, there is dire need in Nigeria for training providers on EC, especially those in the private sector. Training should particularly target PMVs and pharmacists who dominate EC sales (66% of the market combined).
The sale and purchase of EC is legal in Nigeria and is included in the FP and RH service delivery protocol. This is not enough. The service protocol is only visible seemingly on the bookshelves of the Federal Ministry of Health and is not widely distributed to, or read by, intended recipients. It is, indeed, quite striking that only one of 407 providers interviewed understood that EC protects against pregnancy for as many as 120 hours post-intercourse, while EC is included in the national service delivery protocol.
While EC knowledge and attitudes have improved substantially in recent years, negative perceptions are still rife among providers in Nigeria. Over 10 percent of surveyed providers still believe EC is an abortifacient, and the majority is averse to repeated use. Moreover, counseling by providers is not routine for EC clients. Consequently, FP and EC counseling training, EC brochures and information distribution, and national service delivery guideline distribution to all facilities must be given greater attention within FP policies and programs in Nigeria if EC demand and supply is to be significantly improved.
The Nigerian government needs to assume a leadership role in FP and EC commodity procurement and distribution, ensuring availability of high quality and effective products at prices young people can afford. Government officials must be cognizant of the changing realities of young people today. The strong support for EC expressed by interviewed government officials, backed by requisite action, will ensure EC is widely available within public sector facilities and that all of their providers are trained and wellinformed.
While escalating EC use through the public sector is important, the private sector's role must not be ignored; rather, synergy between the two sectors should be fostered. Since Nigeria's private sector is mainly interested in selling EC for profit and provides it to any woman who can buy it, a window of opportunity exists for EC advocates to work with this sector for improving EC supply and demand with, most importantly, improved skills for improved, quality service delivery.
Summary and Conclusions
EC is well-known in urban Nigeria, and is controlled by the largely unregulated and unmonitored private sector, with significant quality and client satisfaction implications. As government continues an indifferent role, FP and EC procurement and supply is almost entirely though donor agencies. This is not a sustainable situation. For EC availability and affordability to become standard and established, in both the private and public sectors, at quality and prices most users can afford, policy action is required, along with increased education for both clients and providers. Important information about EC that should be widely disseminated to both clients and providers includes its legality in Nigeria; its non-interference with established pregnancies; its safety, without adverse effects, for repeated use; its efficacy for as many as 120 hours following unprotected sex; and its suitability for all women, irrespective of age and marital status.
